Paragon Care's Purchase of Somnotec to be Earnings Accretive by Up to 3% in 2026, Euroz Hartleys Says

MT Newswires Live
10/29

Paragon Care's (ASX:PGC) acquisition of healthcare distributor Somnotec will be accretive to earnings per share by around 2% to 3% in fiscal 2026 and 7% in 2027, Euroz Hartleys said in a note on Tuesday.

The medical devices supplier bought Singapore-based Somnotec for an enterprise value of about A$28.4 million.

The deal is projected to accelerate Paragon Care's expansion in Asia and boost its ability to cater to original equipment manufacturers in the region.

Euroz Hartleys kept its buy rating and raised price target to AU$0.61 from AU$0.60.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10